A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring. (2014)

First Author: McNabb B

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/jc.2014-1193

PubMed Identifier: 25127011

Publication URI: http://europepmc.org/abstract/MED/25127011

Type: Journal Article/Review

Volume: 99

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 11

ISSN: 0021-972X